Alemany R - Search Results

1

Retargeting of adenoviral infection to melanoma: combining genetic ablation of native tropism with a recombinant bispecific single-chain diabody (scDb) adapter that binds to fiber knob and HMWMAA.

Nettelbeck DM, Rivera AA, Kupsch J, Dieckmann D, Douglas JT, Kontermann RE, Alemany R, Curiel DT. Nettelbeck DM, et al. Among authors: alemany r. Int J Cancer. 2004 Jan 1;108(1):136-45. doi: 10.1002/ijc.11563. Int J Cancer. 2004. PMID: 14618628 Free article.

2

Complementary adenoviral vectors for oncolysis.

Alemany R, Lai S, Lou YC, Jan HY, Fang X, Zhang WW. Alemany R, et al. Cancer Gene Ther. 1999 Jan-Feb;6(1):21-5. doi: 10.1038/sj.cgt.7700001. Cancer Gene Ther. 1999. PMID: 10078960

3

Gene therapy for gliomas: molecular targets, adenoviral vectors, and oncolytic adenoviruses.

Alemany R, Gomez-Manzano C, Balagué C, Yung WK, Curiel DT, Kyritsis AP, Fueyo J. Alemany R, et al. Exp Cell Res. 1999 Oct 10;252(1):1-12. doi: 10.1006/excr.1999.4623. Exp Cell Res. 1999. PMID: 10502394 Review.

4

Replicative adenoviruses for cancer therapy.

Alemany R, Balagué C, Curiel DT. Alemany R, et al. Nat Biotechnol. 2000 Jul;18(7):723-7. doi: 10.1038/77283. Nat Biotechnol. 2000. PMID: 10888838 Review.

5

Blood clearance rates of adenovirus type 5 in mice.

Alemany R, Suzuki K, Curiel DT. Alemany R, et al. J Gen Virol. 2000 Nov;81(Pt 11):2605-2609. doi: 10.1099/0022-1317-81-11-2605. J Gen Virol. 2000. PMID: 11038370

6

A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency.

Suzuki K, Fueyo J, Krasnykh V, Reynolds PN, Curiel DT, Alemany R. Suzuki K, et al. Among authors: alemany r. Clin Cancer Res. 2001 Jan;7(1):120-6. Clin Cancer Res. 2001. PMID: 11205899

7

Characterization of the cyclooxygenase-2 promoter in an adenoviral vector and its application for the mitigation of toxicity in suicide gene therapy of gastrointestinal cancers.

Yamamoto M, Alemany R, Adachi Y, Grizzle WE, Curiel DT. Yamamoto M, et al. Among authors: alemany r. Mol Ther. 2001 Mar;3(3):385-94. doi: 10.1006/mthe.2001.0275. Mol Ther. 2001. PMID: 11273781 Free article.

8

Human papillomavirus E6E7-mediated adenovirus cell killing: selectivity of mutant adenovirus replication in organotypic cultures of human keratinocytes.

Balagué C, Noya F, Alemany R, Chow LT, Curiel DT. Balagué C, et al. Among authors: alemany r. J Virol. 2001 Aug;75(16):7602-11. doi: 10.1128/JVI.75.16.7602-7611.2001. J Virol. 2001. PMID: 11462032 Free PMC article.

9

Targeting oncolytic adenoviral agents to the epidermal growth factor pathway with a secretory fusion molecule.

Hemminki A, Dmitriev I, Liu B, Desmond RA, Alemany R, Curiel DT. Hemminki A, et al. Among authors: alemany r. Cancer Res. 2001 Sep 1;61(17):6377-81. Cancer Res. 2001. PMID: 11522629

10

CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors.

Alemany R, Curiel DT. Alemany R, et al. Gene Ther. 2001 Sep;8(17):1347-53. doi: 10.1038/sj.gt.3301515. Gene Ther. 2001. PMID: 11571572

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

203 results

Search Page